Get the Stockscreener App
1.33
8.90%
-0.13
Pre-market:
1.30
-0.03
-2.26%
Tevogen Bio Holdings Inc Stock (TVGN) Forecast
The Tevogen Bio Holdings Inc (TVGN) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $12.89, representing a +869.11% increase from the current price of $1.33. The highest analyst price target is $14.02, and the lowest is $11.75.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TVGN Price Target
Average 22.53
(+1,594% Upside)
Is Tevogen Bio Holdings Inc (TVGN) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 45.82 | Neutral |
| STOCH(9,6) | 39.68 | Neutral |
| STOCHRSI(14) | 13.13 | Buy |
| MACD(12,26) | 0.0436 | Sell |
| ADX(14) | 33.97 | Buy |
| William %R | -81.07 | Buy |
| CCI(14) | -66.81 | Neutral |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.473
Sell
|
1.5804
Sell
|
| MA20 |
1.952
Sell
|
1.6136
Sell
|
| MA50 |
1.1357
Buy
|
1.338
Sell
|
| MA100 |
0.8837
Buy
|
1.3868
Sell
|
| MA200 |
1.7768
Sell
|
0.00
Buy
|
Buy: 3
Sell: 7
Neutral: 0
Summary: Sell
According to our latest analysis, TVGN could be considered a Moderate Sell, with 17 technical analysis indicators signaling 6 Buy signals, 8 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on TVGN, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 45.82 indicates that TVGN is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 39.68 indicates that TVGN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 13.13 indicates that TVGN is oversold. This suggests that TVGN price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 33.97 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -66.81 indicates that TVGN is still oversold but not to an extreme extent.
Long-term TVGN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Tevogen Bio Holdings Inc financial reports and earnings history, Tevogen Bio Holdings Inc (TVGN) stock could reach $167.03 by 2030, $334.65 by 2040 and $343.48 by 2050. See the projected annual prices until 2050 of the Tevogen Bio Holdings Inc stock below:
- Tevogen Bio Holdings Inc (TVGN) is expected to reach an average price of $340.63 in 2035, with a high prediction of $340.63 and a low estimate of $55.82. This indicates an $25,511% rise from the last recorded price of $1.33.
- Tevogen Bio Holdings Inc (TVGN) stock is projected to chart a bullish course in 2040, with an average price target of $242.39, representing an $18,125% surge from its current level. The forecast ranges from a conservative $242.72 to a sky-high $334.65.
- Our analysts predict Tevogen Bio Holdings Inc (TVGN) to jump 39,816% by 2045, soaring from $530.89 to an average price of $530.89, potentially reaching $656.61. While $530.89 is the low estimate, the potential upside is significant.
- Tevogen Bio Holdings Inc (TVGN) stock is expected to climb by 2050, reaching an average of $187.80, a $14,020% jump from its current level. However, a wide range of estimates exists, with high and low targets of $343.48 and $187.94, respectively, highlighting the market's uncertainty.
Tevogen Bio Holdings Inc Stock (TVGN) Year by Year Forecast
Tevogen Bio Holdings Inc Stock (TVGN) Price Forecast for 2024
Our forecast for TVGN stock price in 2024 now indicates an average price target of $8.1314 with a high forecast of $16.11 and a low forecast of $0.1528. The average prediction reflects an increase of +511.38% from the last recorded price of $1.33.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $11.23 | $11.75 | $14.02 | +744.61% |
Tevogen Bio Holdings Inc Stock (TVGN) Price Forecast for 2025
Tevogen Bio Holdings Inc Stock (TVGN) is expected to reach an average price of $26.80 in 2025, with a high prediction of $50.27 and a low estimate of $3.3265. This indicates an +1,915% rise from the last recorded price of $1.33.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $7.3366 | $7.4366 | $9.6083 | +451.62% |
| February, 2025 | $24.65 | $3.3265 | $24.65 | +1,753% |
| March, 2025 | $18.40 | $18.81 | $23.17 | +1,283% |
| April, 2025 | $11.99 | $12.22 | $15.59 | +801.49% |
| May, 2025 | $7.2321 | $4.7454 | $9.7187 | +443.76% |
| June, 2025 | $27.43 | $27.43 | $33.19 | +1,963% |
| July, 2025 | $17.87 | $18.21 | $23.25 | +1,244% |
| August, 2025 | $8.8331 | $8.9731 | $14.97 | +564.14% |
| September, 2025 | $36.90 | $6.1642 | $41.73 | +2,674% |
| October, 2025 | $24.48 | $24.88 | $33.12 | +1,741% |
| November, 2025 | $14.09 | $14.28 | $20.17 | +959.13% |
| December, 2025 | $44.34 | $7.5831 | $50.27 | +3,234% |
Tevogen Bio Holdings Inc Stock (TVGN) Price Forecast for 2026
The predicted value for Tevogen Bio Holdings Inc (TVGN) in 2026 is set at an average of $42.45. Estimates vary from a peak of $75.89 to a trough of $9.0019, indicating an +3,091% surge from the present price of $1.33.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $32.39 | $32.57 | $40.02 | +2,335% |
| February, 2026 | $19.59 | $19.69 | $28.43 | +1,373% |
| March, 2026 | $58.81 | $9.0019 | $58.81 | +4,322% |
| April, 2026 | $40.24 | $40.76 | $55.14 | +2,925% |
| May, 2026 | $26.43 | $26.66 | $35.78 | +1,887% |
| June, 2026 | $16.19 | $10.42 | $21.97 | +1,118% |
| July, 2026 | $50.14 | $50.55 | $67.35 | +3,670% |
| August, 2026 | $34.50 | $34.84 | $44.60 | +2,494% |
| September, 2026 | $20.62 | $11.84 | $29.41 | +1,451% |
| October, 2026 | $61.92 | $61.92 | $75.89 | +4,555% |
| November, 2026 | $43.31 | $43.70 | $55.00 | +3,156% |
| December, 2026 | $18.67 | $18.81 | $36.80 | +1,303% |
Tevogen Bio Holdings Inc Stock (TVGN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Tevogen Bio Holdings Inc (TVGN) is $61.65, with a high forecast of $110.05 and a low forecast of $13.26. This indicates an +4,536% increase from the last price of $1.33.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $74.12 | $13.26 | $84.43 | +5,473% |
| February, 2027 | $53.41 | $53.59 | $67.60 | +3,915% |
| March, 2027 | $26.66 | $26.86 | $47.25 | +1,904% |
| April, 2027 | $88.57 | $14.68 | $92.97 | +6,560% |
| May, 2027 | $63.44 | $63.96 | $81.02 | +4,670% |
| June, 2027 | $34.90 | $35.00 | $56.79 | +2,524% |
| July, 2027 | $101.51 | $16.10 | $101.51 | +7,532% |
| August, 2027 | $75.54 | $75.95 | $95.10 | +5,579% |
| September, 2027 | $44.48 | $44.71 | $67.80 | +3,244% |
| October, 2027 | $27.40 | $17.51 | $37.28 | +1,960% |
| November, 2027 | $89.50 | $89.50 | $110.05 | +6,630% |
| December, 2027 | $55.29 | $55.62 | $80.39 | +4,057% |
Tevogen Bio Holdings Inc Stock (TVGN) Price Forecast for 2028
In 2028, Tevogen Bio Holdings Inc (TVGN) is projected to reach an average price of $81.57, with a high projection of $144.21 and a low estimate of $18.93. This indicates an +6,033% rise from the last price of $1.33.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $26.53 | $26.67 | $47.46 | +1,895% |
| February, 2028 | $103.90 | $18.93 | $118.59 | +7,712% |
| March, 2028 | $66.83 | $67.23 | $95.19 | +4,925% |
| April, 2028 | $36.72 | $36.91 | $57.59 | +2,661% |
| May, 2028 | $111.34 | $20.35 | $127.13 | +8,272% |
| June, 2028 | $79.67 | $79.85 | $102.09 | +5,890% |
| July, 2028 | $47.14 | $47.24 | $70.78 | +3,445% |
| August, 2028 | $128.53 | $21.77 | $135.67 | +9,564% |
| September, 2028 | $92.45 | $92.97 | $118.25 | +6,851% |
| October, 2028 | $58.92 | $59.15 | $83.06 | +4,330% |
| November, 2028 | $144.21 | $23.19 | $144.21 | +10,743% |
| December, 2028 | $107.28 | $107.69 | $135.06 | +7,966% |
Tevogen Bio Holdings Inc Stock (TVGN) Price Forecast for 2029
The 2029 price forecast for Tevogen Bio Holdings Inc Stock (TVGN) is $101.49 on average, with a high prediction of $178.37 and a low estimate of $24.61. This represents an +7,531% increase from the previous price of $1.33.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $62.53 | $62.76 | $96.81 | +4,601% |
| February, 2029 | $38.60 | $24.61 | $52.59 | +2,802% |
| March, 2029 | $123.99 | $123.99 | $152.75 | +9,222% |
| April, 2029 | $85.66 | $86.05 | $112.14 | +6,340% |
| May, 2029 | $36.37 | $36.51 | $74.22 | +2,634% |
| June, 2029 | $141.12 | $26.03 | $161.29 | +10,510% |
| July, 2029 | $100.69 | $100.87 | $129.67 | +7,470% |
| August, 2029 | $49.29 | $49.49 | $89.60 | +3,606% |
| September, 2029 | $160.50 | $27.45 | $169.83 | +11,968% |
| October, 2029 | $105.94 | $106.12 | $148.02 | +7,865% |
| November, 2029 | $62.46 | $62.56 | $94.31 | +4,596% |
| December, 2029 | $178.37 | $28.87 | $178.37 | +13,311% |
Tevogen Bio Holdings Inc Stock (TVGN) Price Forecast for 2030
Tevogen Bio Holdings Inc Stock (TVGN) is expected to reach an average price of $117.14 in 2030, with a high forecast of $203.99 and a low forecast of $30.28. This signifies an +8,707% surge from the last price of $1.33.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $121.45 | $121.98 | $167.03 | +9,032% |
| February, 2030 | $76.97 | $77.20 | $109.32 | +5,687% |
| March, 2030 | $47.56 | $30.28 | $64.84 | +3,476% |
| April, 2030 | $151.57 | $151.57 | $186.91 | +11,296% |
| May, 2030 | $92.71 | $93.04 | $137.53 | +6,871% |
| June, 2030 | $44.23 | $44.37 | $79.95 | +3,226% |
| July, 2030 | $158.47 | $31.70 | $195.45 | +11,815% |
| August, 2030 | $109.18 | $109.58 | $143.88 | +8,109% |
| September, 2030 | $59.35 | $59.54 | $95.01 | +4,362% |
| October, 2030 | $178.34 | $33.12 | $203.99 | +13,309% |
| November, 2030 | $126.95 | $127.13 | $164.16 | +9,445% |
| December, 2030 | $74.70 | $74.80 | $113.13 | +5,517% |
3.66%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):